Luye Pharma eyes $750m Q2 IPO
China’s Luye Pharma Group is planning to conduct a $750m Hong Kong IPO as early as the second quarter, according to a banker close to the deal.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts